MDG_0000000001 - Infant mortality rate (between birth and 11 months per 1000 live births)
MDG_0000000003 - Adolescent birth rate (per 1000 women)
MDG_0000000007 - Under-five mortality rate (per 1000 live births) (SDG 3.2.1)
MDG_0000000010 - Median availability of selected generic medicines (%) - Public
MDG_0000000011 - Median consumer price ratio of selected generic medicines - Public
MDG_0000000015 - Prevalence of condom use by adults during higher-risk sex (15-49) (%)
MDG_0000000017 - Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
MDG_0000000020 - Incidence of tuberculosis (per 100 000 population per year)
MDG_0000000021 - Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%)
MDG_0000000025 - Births attended by skilled health personnel (%)
MDG_0000000026 - Maternal mortality ratio (per 100 000 live births)
LIFE_0000000029 - nMx - age-specific death rate between ages x and x+n
LIFE_0000000031 - lx - number of people left alive at age x
WHS3_41 - Diphtheria - number of reported cases
WHS3_42 - Japanese encephalitis - number of reported cases
WHS3_43 - Pertussis - number of reported cases
WHS3_45 - Number of new leprosy cases
WHS3_46 - Total tetanus - number of reported cases
WHS3_49 - Poliomyelitis - number of reported cases
WHS3_50 - Yellow fever - number of reported cases
WHS3_53 - Mumps - number of reported cases
WHS3_55 - Congenital Rubella Syndrome - number of reported cases
WHS3_56 - Neonatal tetanus - number of reported cases
WHS3_57 - Total rubella - number of reported cases
WHS3_62 - Measles - number of reported cases
WHOSIS_000001 - Life expectancy at birth (years)
WHOSIS_000002 - Healthy life expectancy (HALE) at birth (years)
WHOSIS_000003 - Neonatal mortality rate (0 to 27 days) per 1000 live births) (SDG 3.2.2)
WHOSIS_000004 - Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
WHOSIS_000006 - Infants exclusively breastfed for the first six months of life (%)
WHS4_100 - Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
WHS6_101 - Median availability of selected generic medicines (%) - Private
WHS6_102 - Hospital beds (per 10 000 population)
WHS4_106 - Care-seeking for children with symptoms of acute respiratory infection (%)
WHS8_110 - Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
WHS4_111 - Antenatal care coverage - at least one visit (%)
WHS4_115 - Births by caesarean section (%)
WHS6_116 - Median consumer price ratio of selected generic medicines - Private
WHS4_117 - Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
WHS2_126 - Distribution of years of life lost by major cause group
WHS4_128 - Neonates protected at birth against neonatal tetanus (PAB) (%)
WHS4_129 - Hib (Hib3) immunization coverage among 1-year-olds (%)
WHS2_131 - Age-standardized NCD mortality rate (per 100 000 population)
WHS2_138 - Deaths due to HIV/AIDS (per 100 000 population)
WHS4_154 - Antenatal care coverage - at least four visits (%)
WHS2_174 - Distribution of years of life lost by broader causes (%) - Injuries
ODA_1 - Donor commitments (Million, constant 2009 US$)
ODA_2 - Commitments to recipient countries (Million, constant 2009 US$)
ODA_3 - Donor disbursements (Million, constant 2009 US$)
ODA_4 - Disbursements to recipient countries (Million, constant 2009 US$)
GBD_DALYRTAGE - Age-standardized DALYs (per 100,000)
CHOLERA_0000000001 - Number of reported cases of cholera
CHOLERA_0000000002 - Number of reported deaths from cholera
CHOLERA_0000000003 - Cholera case fatality rate
RS_193 - Income level
RS_194 - Number of registered vehicles
RS_196 - Estimated number of road traffic deaths
RS_198 - Estimated road traffic death rate (per 100 000 population)
RS_204 - Existence of a national drink-driving law
RS_208 - Attribution of road traffic deaths to alcohol (%)
RS_209 - Existence of a national seat-belt law
RS_210 - Applicability of seat-belt law to all occupants
RS_213 - Existence of a national child-restraint law
RS_214 - Existence of national speed limits
RS_225 - Existence of a road safety lead agency
RS_228 - Existence of a national road safety strategy
RS_229 - Availability of funding for national road safety strategy
RS_237 - Existence of a formal pre-hospital care system
RS_205 - Definition of drink-driving by BAC
RS_246 - Distribution of road traffic deaths by type of road user (%)
RS_207 - Blood Alcohol Concentration (BAC) limit for drivers
RS_212 - Seat-belt wearing rate (%)
RS_219 - Applicability of national motorcycle helmet law to all occupants
RS_238 - Existence of a universal access telephone number for pre-hospital care
RS_217 - Maximum speed limits
RS_576 - Gross national income per capita (Atlas method)
MDG_0000000029 - Prevalence of HIV among adults aged 15 to 49 (%)
MDG_0000000030 - Smear-positive tuberculosis case-detection rate (%)
MDG_0000000031 - Smear-positive tuberculosis treatment-success rate (%)
WHS5_512 - Population using solid fuels (%)
MDG_0000000032 - Maternal mortality ratio (per 100 000 live births) - Country reported estimates
NUTRITION_564 - Children aged <5 years wasted for age (%)
NUTRITION_570 - Early initiation of breastfeeding (%)
NUTRITION_579 - Exclusive breastfeeding under 6 months (%)
WHS4_543 - BCG immunization coverage among 1-year-olds (%)
WHS4_544 - Polio (Pol3) immunization coverage among 1-year-olds (%)
SA_0000001398 - Alcohol, consumption of pure alcohol by type of beverage (%)
SA_0000001400 - Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)
SA_0000001401 - Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
SA_0000001402 - Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010
SA_0000001403 - Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)
SA_0000001404 - Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol
SA_0000001405 - Alcohol, tourist consumption (in litres of pure alcohol)
SA_0000001406 - Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)
MDG_0000000033 - Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
MDG_0000000034 - Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines
SA_0000001409 - Alcohol, abstainers lifetime (%)
SA_0000001410 - Abstainers (15-19 years), lifetime (%)
SA_0000001411 - Alcohol, abstainers past 12 months (%)
SA_0000001412 - Abstainers (15-19 years), past 12 months (%)
SA_0000001413 - Alcohol, consumers past 12 months (%)
SA_0000001414 - Alcohol, former drinkers (%)
SA_0000001416 - Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)
SA_0000001417 - Alcohol, patterns of drinking score
SA_0000001418 - Age-standardized DALYs, alcohol use disorders, per 100,000
SA_0000001419 - Age-standardized DALYs, breast cancer, per 100,000
SA_0000001420 - Age-standardized DALYs, colon and rectum cancers, per 100,000
SA_0000001421 - Age-standardized DALYs, diabetes mellitus, per 100,000
SA_0000001422 - Age-standardized DALYs, drownings, per 100,000
SA_0000001423 - Age-standardized DALYs, falls, per 100,000
SA_0000001424 - Age-standardized DALYs, fires, per 100,000
SA_0000001425 - Age-standardized DALYs, ischaemic heart disease, per 100,000
SA_0000001426 - Age-standardized DALYs, liver cancer, per 100,000
SA_0000001427 - Age-standardized DALYs, liver cirrhosis, per 100,000
SA_0000001429 - Age-standardized DALYs, mouth and oropharynx cancer, per 100,000
SA_0000001430 - Age-standardized DALYs, oesophagus cancer, per 100,000
SA_0000001431 - Age-standardized DALYs, poisoning, per 100,000
SA_0000001432 - Age-standardized DALYs, prematurity and low birth rate, per 100,000
SA_0000001433 - Age-standardized DALYs, road traffic accidents, per 100,000
SA_0000001434 - Age-standardized DALYs, self-inflicted injury, per 100,000
SA_0000001435 - Age-standardized DALYs, other unintentional injuries, per 100,000
SA_0000001436 - Age-standardized DALYs, violence, per 100,000
SA_0000001437 - Age-standardized death rates, alcohol use disorders, per 100,000
SA_0000001438 - Age-standardized death rates, breast cancer, per 100,000
SA_0000001439 - Age-standardized death rates, colon and rectum cancers, per 100,000
SA_0000001440 - Age-standardized death rates, diabetes mellitus, per 100,000
SA_0000001441 - Age-standardized death rates, drownings, per 100,000
SA_0000001442 - Age-standardized death rates, falls, per 100,000
SA_0000001443 - Age-standardized death rates, fires, per 100,000
SA_0000001444 - Age-standardized death rates, ischaemic heart disease, per 100,000
SA_0000001445 - Age-standardized death rates, liver cancer, per 100,000
SA_0000001446 - Age-standardized death rates, liver cirrhosis, per 100,000
SA_0000001448 - Age-standardized death rates, mouth and oropharynx cancer, per 100,000
SA_0000001449 - Age-standardized death rates, oesophagus cancer, per 100,000
SA_0000001450 - Age-standardized death rates, poisoning, per 100,000
SA_0000001451 - Age-standardized death rates, prematurity and low birth rate, per 100,000
SA_0000001452 - Age-standardized death rates, road traffic accidents, per 100,000
SA_0000001453 - Age-standardized death rates, self-inflicted injury, per 100,000
SA_0000001454 - Age-standardized death rates, other unintentional injuries, per 100,000
SA_0000001455 - Age-standardized death rates, violence, per 100,000
SA_0000001456 - Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000
SA_0000001457 - Liver cirrhosis, age-standardized death rates (15+), per 100,000 population
SA_0000001458 - Age-standardized death rates (15+ years), poisoning, per 100,000
SA_0000001459 - Road traffic injuries, age-standardized death rates (15+), per 100,000 population
SA_0000001460 - Age-standardized death rates (15+ years), violence, per 100,000
SA_0000001461 - Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI
SA_0000001462 - Alcohol use disorders (15+), 12 month prevalence (%) with 95%
SA_0000001463 - Alcoholic psychosis, incidence, per 100,000
SA_0000001464 - Cautions and arrests for drink-driving, per 100,000 population
SA_0000001465 - Hospital discharges, alcohol-related injuries and poisoning, per 100,000
SA_0000001466 - Hospital discharges, alcoholic liver disease, per 100,000
SA_0000001467 - Perceived trend in alcohol-related harm and consequences
SA_0000001468 - Treatment admissions (inpatient), alcohol dependence, per 100,000
SA_0000001469 - Treatment admissions (inpatient), alcoholic psychosis, per 100,000
SA_0000001470 - Alcohol-related road traffic crashes, per 100,000 population
SA_0000001471 - Alcohol-related road traffic crashes (% of all traffic crashes)
SA_0000001472 - Alcohol-related injury mortality, per 1,000
SA_0000001473 - Alcohol-related disease mortality, per 100,000 (15+ years)
SA_0000001474 - Alcoholic excise tax revenue as a per cent of government revenue
SA_0000001475 - Annual revenues from alcohol excise tax in millions US$
SA_0000001476 - Alcohol expenditure as a per cent of total household expenditure
SA_0000001477 - Social costs of alcohol use in millions US$
HIV_0000000001 - Number of people (all ages) living with HIV
HIV_0000000006 - Number of people dying of HIV-related causes
HIV_0000000007 - Testing and counselling facilities, reported number
HIV_0000000008 - Testing and counselling facilities, estimated number per 100 000 adult population
HIV_0000000009 - Reported number of people receiving antiretroviral therapy
HIV_0000000011 - Reported number of children receiving antiretroviral therapy
HIV_0000000012 - Reported number of children receiving antiretroviral therapy, month and year of report
HIV_0000000015 - Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
HIV_0000000020 - Estimated number of pregnant women living with HIV
HIV_0000000021 - Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission
HIV_0000000022 - Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
HIV_0000000023 - Estimated number of children needing antiretroviral therapy based on WHO methods
HIV_0000000024 - Estimated antiretroviral therapy coverage among children
SA_0000001502 - Adopted written national policy on alcohol
SA_0000001503 - Alcoholic beverage legally defined
SA_0000001504 - Alcohol use is banned
SA_0000001506 - National legislation to prevent illegal alcohol
WSH_1 - WASH deaths (number) (SDG 3.9.2)
WSH_2 - Water, sanitation and hygiene attributable deaths ('000) in children under 5 years
WSH_3 - Water, sanitation and hygiene attributable deaths per 100'000 capita
WSH_4 - Water, sanitation and hygiene attributable deaths per 100'000 children under 5 years
WSH_5 - Water, sanitation and hygiene attributable DALYs ('000)
WSH_6 - Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years
WSH_7 - Water, sanitation and hygiene attributable DALYs per 100'000 capita
WSH_8 - Water, sanitation and hygiene attributable DALYs per 100'000 children under 5 years
AIR_4 - Ambient air pollution attributable deaths in children under 5 years
AIR_5 - Ambient air pollution attributable death rate (per 100 000 population)
AIR_6 - Ambient air pollution attributable deaths per 100'000 children under 5 years
AIR_7 - Ambient air pollution attributable DALYs
AIR_8 - Ambient air pollution attributable DALYs in children under 5 years
AIR_9 - Ambient air pollution attributable DALYs (per 100 000 population)
AIR_10 - Ambient air pollution attributable DALYs per 100'000 children under 5 years
AIR_11 - Household air pollution attributable deaths
AIR_12 - Household air pollution attributable deaths in children under 5 years
AIR_15 - Household air pollution attributable DALYs
AIR_16 - Household air pollution attributable DALYs in children under 5 years
AIR_17 - Household air pollution attributable DALYs (per 100 000 population)
TB_1 - Tuberculosis treatment coverage
MENING_1 - Number of suspected meningitis deaths reported
MENING_2 - Number of suspected meningitis cases reported
TB_e_mort_exc_tbhiv_num - Number of deaths due to tuberculosis, excluding HIV
TB_e_prev_num - Number of prevalent tuberculosis cases
TB_e_inc_num - Number of incident tuberculosis cases
TB_e_inc_tbhiv_100k - Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
TB_e_inc_tbhiv_num - Number of incident tuberculosis cases, (HIV-positive cases)
TB_tot_newrel - Tuberculosis - new and relapse cases (TB_c_newinc)
SA_0000001507 - Advertising restrictions on national television
SA_0000001508 - Advertising restrictions on cable television
SA_0000001509 - Advertising restrictions on national radio
SA_0000001510 - Advertising restrictions on local radio
SA_0000001511 - Advertising restrictions in print media
SA_0000001512 - Advertising restrictions at cinemas
SA_0000001513 - Advertising restrictions on billboards
SA_0000001514 - Advertising restrictions at point-of-sale
SA_0000001515 - Advertising restrictions on the internet
SA_0000001516 - Restrictions on product placement on national television
SA_0000001517 - Restrictions on product placement on cable television
SA_0000001518 - Age limits on-premise service
SA_0000001519 - Minimum legal drinking age
SA_0000001520 - Legal blood alcohol concentration (BAC) limits
SA_0000001521 - Random breath testing (RBT) use
SA_0000001523 - Prices for alcoholic beverages (average, US$)
SA_0000001525 - Off-premise sales restrictions on days
SA_0000001526 - Off-premise sales restrictions on hours
SA_0000001527 - Off-premise sales restrictions on places
SA_0000001528 - Off-premise sales restrictions on outlet density
SA_0000001529 - Off-premise sales restrictions at specific events
SA_0000001530 - Off-premise sales restrictions at petrol stations
SA_0000001531 - On-premise sales restrictions on days
SA_0000001532 - On-premise sales restrictions on hours
SA_0000001533 - On-premise sales restrictions on places
SA_0000001534 - On-premise sales restrictions on outlet density
SA_0000001535 - On-premise sales restrictions at specific events
SA_0000001536 - On-premise sales restrictions to intoxicated persons (archived)
SA_0000001537 - Restrictions on sponsorship of sporting events
SA_0000001538 - Restrictions on sponsorship of youth events
SA_0000001539 - Restrictions on sales promotion from producers (parties, events)
SA_0000001540 - Restrictions on sales promotion from retailers (sales below cost)
SA_0000001541 - Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
SA_0000001542 - Government monopoly on production
SA_0000001543 - Government monopoly on retail sales
SA_0000001544 - Licence required for production
SA_0000001545 - Licence required for retail sales
SA_0000001546 - Excise tax as a per cent of the retail price of alcoholic beverages
SA_0000001547 - Excise duty (average) per hectolitre in Euros
SA_0000001548 - Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
SA_0000001549 - Duty paid or excise stamp on alcohol container
SA_0000001550 - Excise tax on alcoholic beverages
SA_0000001551 - Value-added tax (VAT) on alcohol (%)
SA_0000001553 - Restrictions on alcohol use in public places
SA_0000001554 - Health warning labels on alcohol advertising
SA_0000001555 - Health warning labels on alcohol containers
SA_0000001651 - Monitoring
SA_0000001653 - Treatment, services
SA_0000001652 - Interventions, projects, training
SA_0000001647 - Awareness activities
SA_0000001648 - Information, education, prevention
SA_0000001650 - Standard drink measures, in grams per unit
SA_0000001649 - National drinking guidelines, 2010
SA_0000001676 - Production in 1000s hectolitres
SA_0000001677 - Imports in 1000s hectolitres
SA_0000001678 - Sales of beer in 1000s hectolitres
SA_0000001679 - Exports of beer (barley) in 1000s hectolitres
SA_0000001680 - Perceived trend in production
SA_0000001681 - Perceived trend in imports
SA_0000001682 - Perceived trend in sales
SA_0000001683 - Perceived trend in exports
SA_0000001654 - Surveys, research
SA_0000001655 - Counselling
SA_0000001684 - Sales of wine in 1000s hectolitres
SA_0000001685 - Sales of spirits in 1000s hectolitres
SA_0000001686 - Exports of wine (grape) in 1000s hectolitres
SA_0000001687 - Exports of spirits in 1000s hectolitres
TB_new_sp - New cases: Pulmonary, smear-positive
TB_new_sn - New cases: pulmonary smear-negative
TB_new_su - New cases: pulmonary smear unknown/not done
TB_new_ep - New cases: extrapulmonary
TB_new_oth - New cases: other
TB_ret_rel - Relapse cases (pre-2013 definition)
TB_ret_taf - Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
TB_ret_tad - Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
TB_ret_oth - Retreatment cases: other
TB_newret_oth - Treatment history unknown
TB_c_lab_sm_100k - Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
TB_c_lab_cul_5m - Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
TB_c_lab_dst_5m - Laboratories providing drug susceptibility testing (DST) (per 5 million population)
TB_sldst_avail - Second-line drug susceptibility testing (DST) available
TB_c_new_snep_tsr - Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases
TB_c_ret_tsr - Treatment success rate: previously treated TB cases
NCD_BMI_25A - Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)
NCD_BMI_25C - Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)
NCD_BMI_30A - Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)
NCD_BMI_30C - Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)
NCD_PAA - Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)
NCD_PAC - Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)
TOTENV_1 - Deaths attributable to the environment
TOTENV_2 - Age-standardized deaths attributable to the environment (per 100 000 population)
TOTENV_3 - Disability-adjusted life years (DALYs) attributable to the environment
TOTENV_4 - Age-standardized DALYs attributable to the environment (per 100 000 population)
TOTENV_5 - Deaths attributable to the environment (%)
TOTENV_6 - Disability-adjusted life years (DALYs) attributable to the environment (%)
UV_1 - UV radiation
UV_2 - UV radiation attributable deaths
UV_3 - UV radiation attributable DALYs ('000)
UV_4 - UV radiation attributable deaths per 100'000 capita
UV_5 - UV radiation attributable DALYs per 100'000 capita
NCD_CCS_CVDPlan - Existence of operational policy/strategy/action plan for cardiovascular diseases
NCD_CCS_CancerPlan - Existence of operational policy/strategy/action plan for cancer
NCD_CCS_DiabPlan - Existence of operational policy/strategy/action plan for diabetes
NCD_CCS_CRDPlan - Existence of operational policy/strategy/action plan for chronic respiratory diseases
NCD_CCS_AlcPlan - Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol
NCD_CCS_DietPlan - Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs
NCD_CCS_PAPlan - Existence of operational policy/strategy/action plan to reduce physical inactivity
NCD_CCS_TobPlan - Existence of operational policy/strategy/action plan to decrease tobacco use
NCD_CCS_CervCy - General availability of cervical cytology at the primary health care level
NCD_CCS_BowelCancer - General availability of colon cancer screening at the primary health care level
NCD_CCS_BreastCancer - General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
NCD_CCS_DiabetesTest - General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level
NCD_CCS_CholMsmt - General availability of total cholesterol measurement at the primary health care level
NCD_CCS_Spirom - General availability of spirometry at the primary health care level
NCD_CCS_Insulin - General availability of insulin in the public health sector
NCD_CCS_Aspirin - General availability of aspirin (100 mg) in the public health sector
NCD_CCS_Metformin - General availability of metformin in the public health sector
NCD_CCS_Thiazide - General availability of thiazide diuretics in the public health sector
NCD_CCS_ACE - General availability of ACE inhibitors in the public health sector
NCD_CCS_CCBlkrs - General availability of CC blockers in the public health sector
NCD_CCS_Statins - General availability of statins in the public health sector
NCD_CCS_OralMorph - General availability of oral morphine in the public health sector
NCD_CCS_Nicotine - General availability of nicotine replacement therapy in the public health sector
NCD_CCS_Steroid - General availability of steroid inhalers in the public health sector
BP_03 - Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)
BP_04 - Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)
BP_05 - Mean systolic blood pressure (crude estimate)
BP_06 - Mean systolic blood pressure (age-standardized estimate)
RS_1845 - Population
NCD_DTH_TOT - Total NCD Deaths (in thousands)
NCD_UNDER70 - Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths (%)
WHOSIS_000014 - Stillbirth rate (per 1000 total births)
NCD_GLUC_01 - Mean fasting blood glucose (mmol/l) (age-standardized estimate)
NCD_GLUC_02 - Mean fasting blood glucose (mmol/l) (crude estimate)
NCD_GLUC_03 - Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate)
NCD_GLUC_04 - Raised fasting blood glucose (>=7.0 mmol/L) (age-standardized estimate)
WHS6_100 - Radiotherapy units (per 1 000 000 population)
NTD_1 - Number of new reported cases of Buruli ulcer
NTD_4 - Number of new reported cases of human African trypanosomiasis (T.b. gambiense)
NTD_5 - Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense)
NTD_6 - Status of elimination of trachoma as a public health problem
NTD_7 - Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem
NTD_8 - Number of people who received treatment with antibiotics for trachoma
MENING_3 - Number of meningitis epidemic districts
SA_0000001688 - Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)
WHS4_111_AGE1519 - Antenatal care coverage - at least one visit, among girls aged 15-19 (%)
HWWS_2 - Handwashing with soap after cleaning child's stool (%)
HWWS_1 - Handwashing with soap after using the toilet (%)
RSUD_1 - Point prevalence (%), alcohol use disorders, 15+ years
RSUD_2 - Point prevalence (%), drug use disorders, 15+ years
RSUD_3 - Age-standardized death rates, alcohol and drug use disorders, per 100 000
RSUD_5 - Age-standardized DALYs, alcohol and drug use disorders, per 100 000
RSUD_7 - Psychoactive substance causing entry into treatment
SA_0000001689 - Age-standardized DALYs, cerebrovascular disease, per 100,000
SA_0000001690 - Age-standardized death rates, cerebrovascular disease, per 100,000
RSUD_8 - Epidemiological data collection system for substance use disorders
RSUD_9 - Service delivery data collection system for substance use disorders
RSUD_10 - National survey on substance use among children and adolescents
RSUD_11 - Data on substance use disorders disseminated in national annual reports
RSUD_12 - Substance use policy at the national level
RSUD_13 - Substance use policy at the national level, level of integration
RSUD_14 - Policy documents on the pharmacological treatment of substance use disorders
RSUD_15 - Guidelines on the pharmacological treatment of substance use disorders
RSUD_16 - Legislative provision for treatment and rehabilitation of substance use disorders
RSUD_17 - Legislative provision for compulsory treatment
RSUD_18 - Drug courts
RSUD_19 - Programmes diverting clients from the justice system towards treatment
RSUD_20 - Confidentiality of health records on substance use disorders protected by law
RSUD_21 - Government unit for substance use disorder treatment
RSUD_22 - Budget line for substance use disorder treatment
RSUD_23 - Financing method for substance use disorder treatment
RSUD_26 - Governement benefits for persons with substance use disorders
RSUD_27 - Government benefits for alcohol use disorders, subsidy or disability pension
RSUD_28 - Government benefits for drug use disorders, subsidy or disability pension
RSUD_29 - Sector for inpatient detoxification of alcohol use disorders
RSUD_30 - Sector for inpatient treatment of alcohol dependence
RSUD_31 - Sector for outpatient treatment of alcohol dependence
RSUD_32 - Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
RSUD_33 - Sector for residential long-term rehabilitation of alcohol use disorders
RSUD_34 - Sector for inpatient detoxification of drug use disorders
RSUD_35 - Sector for inpatient treatment of drug dependence
RSUD_36 - Sector for outpatient treatment of drug dependence
RSUD_37 - Sector for substitution maintenance therapy of opioid dependence
RSUD_38 - Sector for residential long-term rehabilitation of drug use disorders
RSUD_39 - Treatment system for substance use disorders
RSUD_40 - Treatment setting for substance use disorders, most common
RSUD_41 - Specialized treatment services for drug use disoders and HIV/AIDS
RSUD_42 - Specialized treatment services for substance use disorders and TB
RSUD_43 - Open access services for substance use disorders
RSUD_44 - Treatment slots for alcohol and drug use disorders, outpatient, per 10 000
RSUD_45 - Beds for the treatment of substance use disorders, per 100 000
RSUD_46 - Length of stay for inpatient detoxification, days
RSUD_47 - Length of stay for inpatient short-term treatment, days
RSUD_48 - Length of stay for inpatient long-term residential treatment, days
CM_01 - Number of deaths among children under-five
CM_02 - Number of infant deaths (between birth and 11 months)
CM_03 - Number of neonatal deaths (0 to 27 days)
RSUD_49 - Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
RSUD_50 - Timeframe of opioid agonist treatment
RSUD_51 - Methadone used for the treatment of opioid dependence
RSUD_52 - Methadone used for detoxification or maintenance
RSUD_53 - Methadone formulation used for the treatment of opiod dependence
RSUD_54 - Buprenorphine used for the treatment of opioid dependence
RSUD_55 - Buprenorphine used for detoxification or maintenance
RSUD_56 - Buprenorphine/naloxone used for the treatment of opioid dependence
RSUD_57 - Buprenorphine/naloxone used for detoxification or maintenance
RSUD_58 - Methadone provision in clinical and community-based settings
RSUD_59 - Buprenorphine provision in clinical and community-based settings
RSUD_60 - Buprenorphine/naloxone provision in clinical and community-based settings
RSUD_61 - Supervision requirements for methadone administration
RSUD_62 - Supervision requirements for buprenorphine administration
RSUD_63 - Supervision requirements for buprenorphine/naloxone administration
RSUD_64 - Prescription requirements for methadone
RSUD_65 - Prescription requirements for buprenorphine
RSUD_66 - Prescription requirements for buprenorphine/naloxone
RSUD_67 - Commencement of treatment with opioid agonists
RSUD_68 - Pharmacotherapy used for the management of alcohol withdrawal
RSUD_69 - Pharmacotherapy used for the management of benzodiazepine withdrawal
RSUD_70 - Pharmacotherapy used for the management of cannabis withdrawal
RSUD_71 - Essential list of medicines
RSUD_72 - Essential list of medicines, pharmacotherapy for substance use disorders
NUTRITION_2005 - Proportion of children aged 6-23 months who receive a minimum acceptable diet
RSUD_73 - Government unit for substance use disorder prevention
RSUD_74 - Budget line for substance use disorder prevention
RSUD_75 - Funding method for substance use disorder prevention
RSUD_76 - Prevention activities for substance use disorders, main focus
RSUD_77 - Programmes for the prevention of substance use disorders for special populations
RSUD_78 - Screening and brief interventions for substance use and substance use disorders
RSUD_79 - Harm reduction programmes for IDUs
RSUD_80 - Health professionals mostly involved in treatment of substance use disorders
RSUD_81 - Clinical supervision of health care staff
RSUD_82 - Standards of care for health professionals
RSUD_83 - Standards of care for health professionals, maintenance
RSUD_84 - Standards of care for health professionals, human rights
RSUD_85 - NGOs for alcohol use disorders
RSUD_86 - NGOs for drug use disorders
RSUD_87 - Self-help groups for substance use disorders
RSUD_88 - Groups and agencies for the prevention of substance use disorders
MH_1 - Mental health policy
MH_2 - Mental health plan
MH_3 - Stand-alone law for mental health
MH_4 - Government expenditures on mental health as a percentage of total government expenditures on health (%)
MH_5 - Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
MH_6 - Psychiatrists working in mental health sector (per 100 000 population)
MH_7 - Nurses working in mental health sector (per 100 000 population)
MH_8 - Social workers working in mental health sector (per 100 000 population)
MH_9 - Psychologists working in mental health sector (per 100 000 population)
MH_10 - Mental health outpatient facilities (per 100 000 population)
MH_11 - Mental health day treatment facilities (per 100 000 population)
MH_12 - Age-standardized suicide rates (per 100 000 population)
MH_13 - Beds for mental health in general hospitals (per 100 000 population)
MH_14 - Community residential facilities (per 100 000 population)
MH_15 - Beds in community residential facilities (per 100 000 population)
MH_16 - Beds in mental hospitals (per 100 000 population)
RSUD_89 - Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
MH_17 - Mental hospitals (per 100 000 population)
MH_18 - Mental health units in general hospitals (per 100 000 population)
WHOSIS_000015 - Life expectancy at age 60 (years)
DEVICES01 - Total density per 100 000 population: Health posts
DEVICES02 - Total density per 100 000 population: Health centres
DEVICES03 - Total density per 100 000 population: District/rural hospitals
DEVICES04 - Total density per 100 000 population: Provincial hospitals
DEVICES05 - Total density per 100 000 population: Specialized hospitals
DEVICES06 - Availability of national standards or recommended lists of medical devices
DEVICES07 - Types of lists recommending health technology for high burden diseases
DEVICES08 - Total density per million population: Magnetic Resonance Imaging
DEVICES09 - Total density per million population: Computed tomography units
DEVICES10 - Total density per million population: Positron Emission tomography
DEVICES11 - Total density per million population: Gamma camera or Nuclear medicine
DEVICES12 - Total density per million population: Linear Accelerator
DEVICES13 - Type of nomenclature system
DEVICES14 - Use of nomenclature system
DEVICES15 - Health technology (medical device) national policy
DEVICES16 - Unit in the Ministry of Health responsible for the management of medical devices
DEVICES17 - Procurement of medical devices carried out at the national level
DEVICES18 - Availability of national list of approved medical devices for procurement or reimbursement
DEVICES19 - National guidelines, policies or recommendations on the procurement of medical devices
DEVICES20 - Availability of technical specifications of medical devices to support procurement or donations
DEVICES21 - Total density per million population: Telecobalt Unit
DEVICES22 - Total density per million population: Radiotherapy units
DEVICES23 - Total density per million females aged from 50 to 69 years old: Mammography units
SA_0000001691 - Central coordinating entity for alcohol policy implementation
SA_0000001692 - Framework of national alcohol policy
SA_0000001693 - Level of adoption of national alcohol policy
SA_0000001694 - Sectors represented in national alcohol policy
SA_0000001695 - Cautions and arrests for public drunkenness, per 100,000 population
SA_0000001696 - Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
WHS10_8 - Civil registration coverage of cause-of-death (%)
WHS10_9 - Ill-defined causes in cause-of-death registration (%)
HIV_0000000025 - Testing and counselling facilities, reporting period
anc1 - Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (%)
cpmt - Contraceptive prevalence - use of modern and traditional methods (%)
ort - Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%)
sba - Births attended by skilled health personnel (in the two or three years preceding the survey) (%)
vita - Children aged 6-59 months who received vitamin A supplementation (%)
anc15 - Antenatal care coverage - at least one visit (in the five years preceding the survey) (%)
anc45 - Antenatal care coverage - at least four visits (in the five years preceding the survey) (%)
csection5 - Births by caesarean section (in the five years preceding the survey) (%)
pncall3 - Postnatal care visit within two days of birth (in the three years preceding the survey) (%)
pncall5 - Postnatal care visit within two days of birth (in the five years preceding the survey) (%)
pnchome3 - Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%)
pnchome5 - Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%)
sba5 - Births attended by skilled health personnel (in the five years preceding the survey) (%)
stunt5 - Stunting prevalence in children aged < 5 years (%) (Health inequality monitor)
asfr1 - Adolescent fertility rate (births per 1000 women aged 15-19 years)
tfr - Total fertility rate (births per woman)
imr - Infant mortality rate (deaths per 1000 live births)
nmr - Neonatal mortality rate (deaths per 1000 live births)
u5mr - Under-five mortality rate (deaths per 1000 live births)
SA_0000001697 - Adopted written national policy on alcohol, year adopted
SA_0000001698 - Adopted written national policy on alcohol, year revised
SA_0000001699 - Age limits off-premise sales
SA_0000001700 - Consumer information on alcohol and health at points of sale
SA_0000001701 - Educational programmes involving target groups in school curriculum
SA_0000001702 - Brief interventions as health promotion/disease prevention
SA_0000001703 - Server training on a regular basis
SA_0000001704 - Data collection on alcohol-related health indicators
SA_0000001705 - System for monitoring alcohol-related harm
SA_0000001706 - National treatment policy for alcohol use disorders
SA_0000001707 - Persons with alcohol use disorders receiving treatment (%)
SA_0000001708 - Designation of alcohol tax revenues to health services
SA_0000001709 - National surveys on drink-driving
SA_0000001710 - Public-funded alcohol research/monitoring programmes
SA_0000001711 - Public funds designated for alcohol research/monitoring programmes, in Euros
SA_0000001712 - Community-based interventions/projects involving stakeholders
SA_0000001713 - Interventions/projects actively involving young people and civil society
SA_0000001714 - Training in screening and brief interventions for alcohol problems
SA_0000001715 - Counselling to children in families with alcohol problems
SA_0000001716 - Counselling to pregnant women with alcohol problems
SA_0000001717 - Prevention/counselling at workplaces for those with alcohol problems
NHABASIS - Basis for NHA estimate
PerctestedANC - Women accessing antenatal care (ANC) services who were tested for syphilis (%), reported
PercposANC - Antenatal care attendees who were positive for syphilis (%), reported
HIV_0000000026 - Number of new HIV infections
NCDMORT3070 - Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease
WHS_PBR - Preterm birth rate (per 100 live births)
CCO_1 - Poverty headcount ratio at $1.25 a day (PPP) (% of population)
CCO_2 - Human development index rank
CCO_3 - Gender inequality index rank
NUTOVERWEIGHTPREV - Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates
NUTOVERWEIGHTNUM - Overweight numbers among children under 5 years of age (millions), model-based estimates
NUTSTUNTINGPREV - Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates
NUTSTUNTINGNUM - Stunting numbers among children under 5 years of age (millions), model-based estimates
M_Group - Monitor
P_Group - Protect from tobacco smoke
O_Group - Offer help to quit tobacco use
W_Group - Warn about the dangers of tobacco
W-MM_Group - Anti-tobacco mass media campaigns
E_Group - Enforce bans on tobacco advertising
R_Group - Raise taxes on tobacco
M_Est_tob_curr - Estimate of current tobacco use prevalence (%)
M_Est_cig_curr - Estimate of current cigarette smoking prevalence (%)
M_survey_title_adult - Name of survey of adults
M_svy_national_adult - Representativeness of survey of adults
M_svy_age_adult - Adult survey age range
M_def_1_text_adult - Adult indicator 1 definition
M_def_1_prev_adult - Adult indicator 1 rate
M_def_2_text_adult - Adult indicator 2 definition
M_def_2_prev_adult - Adult indicator 2 rate
M_smkless_survey_title_adult - Name of survey of adults - smokeless
M_smkless_svy_national_adult - Representativeness of survey of adults - smokeless
M_smkless_age_range_adult - Adult survey age range - smokeless
M_smkless_def_text_adult - Adult smokeless tobacco use indicator definition
M_smkless_prev_adult - Adult smokeless tobacco use indicator rate
M_survey_title_youth - Name of survey of youth
M_svy_national_youth - Representativeness of youth survey
M_svy_age_youth - Youth survey age range
M_def_1_text_youth - Youth indicator 1 definition
M_def_1_prev_youth - Youth indicator 1 rate
M_def_2_text_youth - Youth indicator 2 definition
M_def_2_prev_youth - Youth indicator 2 rate
M_smkless_survey_title_youth - Name of survey of youth - smokeless
M_smkless_svy_national_youth - Representativeness of survey of youth - smokeless
M_smkless_age_range_youth - Youth survey age range - smokeless
M_smkless_def_text_youth - Youth smokeless tobacco use indicator definition
M_smkless_prev_youth - Youth smokeless tobacco use indicator rate
P1_healthcare - Smoke-free health-care facilities (national legislation)
P2_education - Smoke-free education facilities except universities (national legislation)
P3_universities - Smoke-free universities (national legislation)
P4_govt - Smoke-free government facilities (national legislation)
P5_indoor_off - Smoke-free indoor offices (national legislation)
P6_restaurants - Smoke-free restaurants (national legislation)
P7_pubs - Smoke-free pubs, bars and cafés (national legislation)
P8_pub_transp - Smoke-free public transport (national legislation)
P9_all_other - Smoke-free other indoor public places (national legislation)
PC_sfe_compliance - Compliance with regulations on smoke-free environments (national legislation)
P_count_places_sf - Number of places smoke-free (national legislation)
P11_fines_any - Fines for violations of smoke-free laws
P12_fines_establishment - Fines on the establishment for violations of smoke-free laws
P13_fines_smoker - Fines on the patrons of establishments for violations of smoke-free laws
P14_funds_for_enforce - Dedicated funds for enforcement of smoke-free laws
P15_complaints - Citizen complaints and investigations of violations of smoke-free laws
P10_subnat_auth_exists - Subnational smoke-free legislation authority exists
O_Quitline - Access to a toll-free quit line
O_Avail_hosp - Smoking cessation support is available in hospitals
O_Ins_hosp - Smoking cessation support is cost-covered in hospitals
O_Avail_off_hlth_prof - Smoking cessation support is available in offices of health professionals
O_Ins_off_hlth_prof - Smoking cessation support is cost-covered in offices of health professionals
O_Avail_community - Smoking cessation support is available in the community
O_Ins_community - Smoking cessation support is cost-covered in the community
O_Avail_other - Smoking cessation support is available in other settings
O_Ins_other - Smoking cessation support is cost-covered in other settings
O_NRT_sold - Nicotine replacement therapy - legally sold
O_NRT_where - Nicotine replacement therapy - place available
O_NRT_ins - Nicotine replacement therapy - cost covered
O_NRT_EML - Nicotine replacement therapy - on the Essential Medicines List
O_Bup_sold - Bupropion - legally sold
O_Bup_where - Bupropion - place available
O_Bup_ins - Bupropion - cost covered
O_Varen_sold - Varenicline - legally sold
O_Varen_where - Varenicline - place available
O_Varen_ins - Varenicline - cost covered
W1_HW_law_A - Law mandates that health warnings appear on cigarette packages
W2_pc_front_back_A - Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
W3_pc_front_A - Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
W4_pc_back_A - Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
W15_specific_hw_A - Specific health warnings are mandated for cigarette packaging
W16_number_hw_A - Number of health warnings approved by the law for cigarette packaging
W11_outside_pack_A - Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
W14_harm_effects_A - Health warnings on cigarette packaging describe the harmful effects of tobacco use on health
W6_font_A - Font style, font size and colour of health warnings are mandated for cigarette packaging
W7_rotation_A - Health warnings on cigarette packaging must be rotated
W8_princ_langs_A - Health warnings on cigarette packaging must be written in the principal language(s) of the country
W10_graphic_A - Health warnings on cigarette packaging must include a photograph or graphic
W5_top_side_A - Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
W13_ind_liability_A - Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
W12_imports_dutyfree_A - Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
W9_no_obscure_A - Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
W17_fines_A - Health warnings on cigarette packaging law requires or establishes fines for violations
W18_misleading_terms_A - Ban on deceitful terms on cigarette packaging
W19_colours_numbers_A - Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
W20_flavours_A - Cigarette packaging and labelling must not use descriptors depicting flavours
W21_emissions_A - Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark (see W21_emissions_quant_A)
W22_emissions_qual_A - Cigarette packaging and labelling must display qualitative information on emission yields
W23_emissions_front_back_A - Qualitative information on emission yields must be displayed on one or more principle display areas of cigarette packaging
W24_exp_date_A - Display of expiry dates is prevented on cigarette packaging
W25_quitline_number_A - The quit line number must appear on cigarette packaging or labelling
W1_HW_law_C - Law mandates that health warnings appear on smokeless tobacco packages
W2_pc_front_back_C - Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
W3_pc_front_C - Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
W4_pc_back_C - Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
W15_specific_hw_C - Specific health warnings are mandated for smokeless tobacco packaging
W16_number_hw_C - Number of health warnings approved by the law for smokeless tobacco packaging
W11_outside_pack_C - Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
W14_harm_effects_C - Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health
W6_font_C - Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging
W7_rotation_C - Health warnings on smokeless tobacco packaging must be rotated
W8_princ_langs_C - Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
W10_graphic_C - Health warnings on smokeless tobacco packaging must include a photograph or graphic
W5_top_side_C - Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
W13_ind_liability_C - Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
W12_imports_dutyfree_C - Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
W9_no_obscure_C - Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
W17_fines_C - Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
W18_misleading_terms_C - Ban on deceitful terms on smokeless tobacco packaging
W19_colours_numbers_C - Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
W20_flavours_C - Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
W21_emissions_quant_C - Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
W22_emissions_qual_C - Smokeless tobacco packaging and labelling must display qualitative information on emission yields
W23_emissions_front_back_C - Qualitative information on emission yields must be displayed on one or more principle display areas of smokeless tobacco packaging
W24_exp_date_C - Display of expiry dates is prevented on smokeless tobacco packaging
W25_quitline_number_C - The quit line number must appear on smokeless tobacco packaging or labelling
Camp_nat - At least one national mass media campaign ran during the survey period
Camp_gov_prog - Campaign was part of a comprehensive tobacco control programme
Camp_mat_tested - Campaign was pre-tested
Camp_aud_research - Formative research was conducted prior to the campaign
Camp_tv_radio - Campaign ran on both national television and radio
Camp_media_planning - Campaign utilized media planning
Camp_news - Earned media/public relations were used to promote the campaign
Camp_airtime - Process evaluation was employed to assess implementation
Camp_eval_impact - Outcome evaluation was employed to assess effectiveness of the campaign
E1_nat_tv_radio - Ban on advertising on national television and radio
E2_intl_tv_radio - Ban on advertising on international television and radio
E3_nat_print - Ban on advertising in local magazines and newspapers
E4_intl_print - Ban on advertising in international magazines and newspapers
E5_billboards - Ban on billboard and outdoor advertising
E6_pt_of_sale - Ban on advertising: Point of sale
E7_internet - Ban on advertising on the internet
EC_direct_compliance - Compliance with bans on direct advertising
E9_free_distrib - Ban on free distribution in mail or through other means
E10_promo_discounts - Ban on promotional discounts
E11_brand_stretching - Ban on identifying non-tobacco products with tobacco brand names
E12_brand_sharing - Ban on use of brand name of non-tobacco product for tobacco product
E13_brand_placement - Ban on appearance of tobacco brands in TV and/or films (product placement)
E14_prod_tv_films - Appearance of tobacco products in TV and/or films
E15_sponsored_events - Sponsored events
EC_indirect_compliance - Compliance with bans on promotion and sponsorship
E16_csr_promo_self - Ban on tobacco companies/tobacco industry publicizing their Corporate Social Responsibility activities
